| Name |
Azacitidin Pharmascience 25 mg/ml prašak za suspenziju za injekciju |
| Marketing Authorisation Number |
HR-H-961547190 |
| Active Substance |
azacitidin |
| Composition |
Jedna bočica s praškom sadrži 100 mg ili 150 mg azacitidina. Nakon rekonstitucije 1 ml suspenzije sadrži 25 mg azacitidina. |
| Pharmaceutical Form |
prašak za suspenziju za injekciju |
| Manufacturer |
AqVida GmbH, Hamburg, Njemačka |
| Marketing Authorisation Holder |
Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
| Marketing Authorisation Date |
08.08.2025 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/25-02/58 |
| Registration Number |
381-12-01/286-25-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L01BC07 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |